Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

Demon Slayer: Kimetsu no Yaiba follows Tanjiro Kamado's journey as a demon hunter after his family's tragedy. The elite Hashira warriors face devastating losses in their battle against demons ...

Jeffrey Epstein and Prince Andrew’s accuser, Virginia Giuffre, died in April 2025, with her family confirming her death was due to suicide. Giuffre, who was just 41 at the time of her death in ...

Regeneron Pharmaceuticals has a 52-week low of $525.99 and a 52-week high of $1,211.20. The firm has a market capitalization of $65.57 billion, a PE ratio of 15.67, a price-to-earnings-growth ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Tesla stuck to its previously announced June timeline for launching a paid robotaxi service in Austin, Texas, providing investors confidence that Musk's time spent as a government cost-cutting ...

Usha Lee McFarling, a veteran science reporter, has written for STAT since 2015 and covers health disparities. You can reach Usha on Signal at usha.22. It’s hard to remember all the earthshaking ...

How could you do more 1980s-centric stories in the Stranger Things universe, even as the cast becomes too old to play their adolescent selves? Easy, you create an animated version of Stranger ...

An unexpectedly new dish in Vietnam’s long culinary history, this aromatic soup of flat rice noodles, meat, and herbs has traveled far beyond its original roots over a century of change.

Some are household names, others were left out of the spotlight. But all of them changed history. Thurgood Marshall was the first Black U.S. Supreme Court Justice, appointed in 1967 by President ...

Contract manufacturer FujiFilm Diosynth Biotechnologies, which has been expanding its footprint in Holly Springs, has signed a $3 billion agreement to make treatments for Regeneron Pharmaceuticals.